Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia.

Aim To assess the efficacy of propafenone in prevention of atrioventricular nodal reentrant tachycardia (AVNRT) and orthodromic atrioventricular tachycardia (AVRT) based on the clinical results of arrhythmia recurrence and find the electrophysiological predictor of propafenone effectiveness. Methods This retrospective study Included 44 participants in a 12-month period, who were divided In two groups: group A - In which propafenone caused complete ventriculoatrial block and group B - in which propafenone did not cause complete ventriculo-atrial block. Results Group A had significantly lower incidence of tachycardia than group B (95% vs 70.8%, P=0.038), and complete ventriculoatrial block predicted the efficacy of propafenone oral therapy In the prevention of tachycardia (sensitivity 87.5%, specificity 52.8%, positive predictive value 95%, negative predictive value 29.2%). Patients with AVNRT In group B who did not experience the recurrences of tachycardia had significantly shorter echo zone before Intravenous administration of propafenone than the patients who experienced episodes of sustained tachycardia (median 40 ms [range 15-60 ms] vs 79 ms [range 50-180 ms],P= 0.008). Conclusion In patients with non-lnducible tachycardia, complete ventriculoatrial block can be used as an electrophysiological predictor of the efficacy of propafenone oral therapy In the prevention of tachycardia. In patients with non-lnduclble AVNRT, but without complete ventriculoatrial block, propafenone was more effective In patients with shorter echo zone of tachycardia. [ABSTRACT FROM AUTHOR]